Breast Cancer Research Treatment Archives

Strong Impact of MammaPrint and BluePrint on Treatment Decisions in Luminal Early Breast Cancer: Results of the WSG-PRIMe Study
Gallery
Strong Impact of MammaPrint and BluePrint on Treatment Decisions in Luminal Early Breast Cancer: Results of the WSG-PRIMe Study

Adjuvant, BluePrint, Evidence, MammaPrint, WSG-PRIMe

Strong Impact of MammaPrint and BluePrint on Treatment Decisions in Luminal Early Breast Cancer: Results of the WSG-PRIMe Study

PUBLICATION: Breast Cancer Res Treat. (2019) 175: 389. https://doi.org/10.1007/s10549-018-05075-x. AUTHORS: Read More

kevin2024-03-25T11:24:02-07:00June 1st, 2019|Adjuvant, BluePrint, Evidence, MammaPrint, WSG-PRIMe|

Tamoxifen Therapy Benefit for Patients with 70-gene Signature High and Low Risk
Gallery
Tamoxifen Therapy Benefit for Patients with 70-gene Signature High and Low Risk

Endocrine, Evidence, MammaPrint, STO-3

Tamoxifen Therapy Benefit for Patients with 70-gene Signature High and Low Risk

PUBLICATION: Breast Cancer Res Treat (2017) 166: 593. https://doi.org/10.1007/s10549-017-4428-9. AUTHORS: Read More

kevin2024-03-25T08:59:17-07:00November 1st, 2017|Endocrine, Evidence, MammaPrint, STO-3|

A Breast Cancer Gene Signature for Indolent Disease
Gallery
A Breast Cancer Gene Signature for Indolent Disease

Adjuvant, Evidence, MammaPrint, RASTER

A Breast Cancer Gene Signature for Indolent Disease

PUBLICATION: Breast Cancer Res Treat. 2017 Oct;117(3):483-95. doi: 10.1007/s10549-008-0191-2. Epub Read More

kevin2024-03-25T09:05:40-07:00July 1st, 2017|Adjuvant, Evidence, MammaPrint, RASTER|

Genomic Profiling of Breast Cancer in African-American Women Using MammaPrint.
Gallery
Genomic Profiling of Breast Cancer in African-American Women Using MammaPrint.

Evidence, MammaPrint, Other, Racial Disparities

Genomic Profiling of Breast Cancer in African-American Women Using MammaPrint.

PUBLICATION: Breast Cancer Res Treat (2016) 159: 481. https://doi.org/10.1007/s10549-016-3949-y09. AUTHORS: Read More

kevin2024-03-25T09:17:41-07:00August 27th, 2016|Evidence, MammaPrint, Other, Racial Disparities|

Equivalence of MammaPrint Array Types in Clinical Trials and Diagnostics
Gallery
Equivalence of MammaPrint Array Types in Clinical Trials and Diagnostics

Evidence, MammaPrint, Other, Validation

Equivalence of MammaPrint Array Types in Clinical Trials and Diagnostics

PUBLICATION: Breast Cancer Res Treat (2016) 156: 279. https://doi.org/10.1007/s10549-016-3764-5 AUTHORS: Read More

kevin2024-03-25T09:21:49-07:00March 22nd, 2016|Evidence, MammaPrint, Other, Validation|

Molecular Subtyping Improves Diagnostic Stratification of Patients with Primary Breast Cancer into Prognostically-Defined Risk Groups
Gallery
Molecular Subtyping Improves Diagnostic Stratification of Patients with Primary Breast Cancer into Prognostically-Defined Risk Groups

BluePrint, Evidence, Other

Molecular Subtyping Improves Diagnostic Stratification of Patients with Primary Breast Cancer into Prognostically-Defined Risk Groups

PUBLICATION: Breast Cancer Res Treat (2015) 154: 81. https://doi.org/10.1007/s10549-015-3587-9. AUTHORS: Read More

kevin2024-03-25T09:23:03-07:00November 1st, 2015|BluePrint, Evidence, Other|

Gene Expression Profiling to Predict the Risk of Locoregional Recurrence in Breast Cancer: A Pooled Analysis
Gallery
Gene Expression Profiling to Predict the Risk of Locoregional Recurrence in Breast Cancer: A Pooled Analysis

Adjuvant, Evidence, MammaPrint

Gene Expression Profiling to Predict the Risk of Locoregional Recurrence in Breast Cancer: A Pooled Analysis

PUBLICATION: Breast Cancer Res Treat (2014) 148: 599. https://doi.org/10.1007/s10549-014-3188-z. AUTHORS: Read More

kevin2024-03-25T09:27:24-07:00November 24th, 2014|Adjuvant, Evidence, MammaPrint|

Optimized Outcome Prediction in Breast Cancer by Combining the 70-Gene Signature with Clinical Risk Prediction Algorithms
Gallery
Optimized Outcome Prediction in Breast Cancer by Combining the 70-Gene Signature with Clinical Risk Prediction Algorithms

Adjuvant, Evidence, MammaPrint, RASTER

Optimized Outcome Prediction in Breast Cancer by Combining the 70-Gene Signature with Clinical Risk Prediction Algorithms

PUBLICATION: Breast Cancer Res Treat. 2014 Jun;145(3):697-705. doi: 10.1007/s10549-014-2954-2. Epub Read More

kevin2024-03-25T10:21:40-07:00June 1st, 2014|Adjuvant, Evidence, MammaPrint, RASTER|

Mammographic Screening Detects Low-Risk Tumor Biology Breast Cancers
Gallery
Mammographic Screening Detects Low-Risk Tumor Biology Breast Cancers

Adjuvant, Evidence, MammaPrint, MINDACT, Other

Mammographic Screening Detects Low-Risk Tumor Biology Breast Cancers

PUBLICATION: Breast Cancer Res Treat. 2014 Feb;144(1):103-11. doi: 10.1007/s10549-013-2830-5. Epub Read More

kevin2024-03-25T10:25:05-07:00February 2nd, 2014|Adjuvant, Evidence, MammaPrint, MINDACT, Other|

Long-Term Impact of the 70-Gene Signature on Breast Cancer Outcome
Gallery
Long-Term Impact of the 70-Gene Signature on Breast Cancer Outcome

Adjuvant, Evidence, MammaPrint, Other, Validation

Long-Term Impact of the 70-Gene Signature on Breast Cancer Outcome

PUBLICATION: Breast Cancer Res Treat. 2014 Feb;143(3):587-92. doi: 10.1007/s10549-013-2831-4. Epub Read More

kevin2024-03-25T10:40:13-07:00February 1st, 2014|Adjuvant, Evidence, MammaPrint, Other, Validation|